LKT Labs

Biochemicals for Life Science Research

Medroxyprogesterone 17-Acetate

Medroxyprogesterone 17-Acetate

Product ID M1613
Cas No. 71-58-9
Purity ≥98%
Product Unit SizeCostQuantityStock
500 mg $57.10 In stock
1 g $95.20 In stock
5 g $365.90 In stock
Bulk Quote

Quicklinks

Description

Medroxyprogesterone 17-acetate (MPA) is a synthetic steroid that activates progesterone, androgen, and glucocorticoid receptors. MPA exhibits contraceptive and anticancer activities and is also used in hormone replacement therapy, endometriosis, and dysmenorrhea. MPA decreases levels of adrenocorticotropic hormone (ACTH), cortisol, and other hormones; it also inhibits 3α-hydroxysteroid dehydrogenase. This compound is used clinically to treat breast cancer and inhibits the proliferation and growth of breast cancer cells and tumors in various models.

Product Info

Cas No.

71-58-9
Purity

≥98%
Formula

C24H34O4
Formula Wt.

386.52
Chemical Name

17-α-Acetoxy-6α-methylprogesterone
IUPAC Name

[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9, 11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
Synonym

MAP, Clinovir, Depo-Provera, Farlutal, Nidaxin, Oragest, Prodasone, Provera, Veramix
Melting Point

207-209°C
Solubility

Soluble in chloroform or acetone.

Appearance

White to off white powder

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

M1613 MSDS PDF
Info Sheet

M1613 Info Sheet PDF

References

Schindler AE, Campagnoli C, Druckmann R, et al. Classification and pharmacology of progestins. Maturitas. 2008 Sep-Oct;61(1-2):171-80. PMID: 19434889.

Meyer L, Venard C, Schaeffer V, et al. The biological activity of 3alpha-hydroxysteroid oxido-reductase in the spinal cord regulates thermal and mechanical pain thresholds after sciatic nerve injury. Neurobiol Dis. 2008 Apr;30(1):30-41. PMID: 18291663.

Poulin R, Baker D, Poirier D, et al. Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Breast Cancer Res Treat. 1989 Mar;13(2):161-72. PMID: 2525057.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • H1669

    Herbimycin A

    Benzoquinone ansamycin; HSP90, PKC, Src, Bcr-Abl i...
    ≥98%
  • T0110

    Taxane Standard Mixture

    Mixture of taxanes.
    ≥98%
  • A4853

    β-Amyloid Peptide (1-42), human

    Endogenous APP peptide cleavage product, primary c...
    ≥95%
  • P7057

    Protodioscin

    Saponin found in Dioscorea; Na+/K+ ATPase and Ca2+...
    ≥98%
  • W5726

    Wogonin

    Flavonoid found in Scutellaria; CDK9 inhibitor.
    ≥98%
  • W4096

    WKYMVM-NH2

    Synthetic peptide; FPRL1 agonist.
    ≥95%
  • E5178

    Emtricitabine

    Nucleoside (cytidine) analog; RT and telomerase in...
    ≥98%
  • C1622

    CEF6

    Peptide, vSrc-induced cytokine.
    ≥95%
  • D0244

    Dalcetrapib

    Cholesterol ester transfer protein inhibitor.
    ≥98%
  • T0249

    Tamibarotene

    RARα/β agonist.
    ≥98%
  • J6400

    (+)-JQ-1

    Triazolothienodiazepine; BRD inhibitor.
    ≥99%
  • H5748

    D,L-Homocysteine Thiolactone Hydrochloride

    Heterocyclic derivative of cysteine, alters protei...
    ≥98%
  • B5610

    Boc-PRR-AMC

    Peptide, protease substrate.
    ≥98%
  • S0225

    SAG Dihydrochloride

    Smoothened agonist.
    ≥98%
  • J0240

    JAK2 Inhibitor V

    JAK2 inhibitor.
    ≥98%
  • S1872

    Sesamin

    Lignin found in Sesamin indicum;
    ≥98%
  • S7909

    Suc-LEPF-pNA

    Peptide.
    ≥98%
  • E6846

    Erlotinib Hydrochloride

    EGFR inhibitor.
    ≥98%
  • I1418

    Idebenone

    Synthetic quinone CoQ analog, promotes mitochondri...
    ≥98%
  • O4549

    Olmesartan Medoxomil

    AT1 inhibitor.
    ≥98%